Canada markets open in 5 hours 1 minute
  • S&P/TSX

    18,861.36
    -217.24 (-1.14%)
     
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • DOW

    31,097.26
    +321.86 (+1.05%)
     
  • CAD/USD

    0.7775
    +0.0013 (+0.16%)
     
  • CRUDE OIL

    108.21
    -0.22 (-0.20%)
     
  • BTC-CAD

    24,609.33
    -49.83 (-0.20%)
     
  • CMC Crypto 200

    413.02
    -7.12 (-1.69%)
     
  • GOLD FUTURES

    1,808.90
    +7.40 (+0.41%)
     
  • RUSSELL 2000

    1,727.76
    +19.77 (+1.16%)
     
  • 10-Yr Bond

    2.8890
    0.0000 (0.00%)
     
  • NASDAQ futures

    11,535.50
    -75.75 (-0.65%)
     
  • VOLATILITY

    28.01
    -0.70 (-2.44%)
     
  • FTSE

    7,237.03
    +68.38 (+0.95%)
     
  • NIKKEI 225

    26,153.81
    +218.19 (+0.84%)
     
  • CAD/EUR

    0.7453
    +0.0014 (+0.19%)
     

Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript

·23 min read
Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our financial outlook and financing prospects for the future; our outlook for the second quarter of 2022, management's expectations for our future financial and operational performance, including our expectations regarding the growth of Twirla; our business strategy and our assessment of the combined hormonal contraceptive market, among other statements regarding our plans, prospects and expectations. Such statements represent our judgments as of today, are not promises or guarantees, and may involve risks and uncertainties that may cause actual results to differ from the results discussed in the forward-looking statements. Joining me on today's call are Al Altomari, Agile Therapeutics' chairman and chief executive officer; and Dennis Reilly, chief financial officer.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting